Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.33 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.32 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 5/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 5/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23936916 | 0.79 | ALDH1A1 (0.36) | BRD4MAPK14CARM1PRMT6MAPK1 | |
| SCHEMBL23936955 | 0.77 | SMN1; SMN2 (0.37) | CARM1PRMT6MAPK1NPSR1 | |
| SCHEMBL21214040 | 0.76 | CYP2D6 (0.31) | CXCR3KCNH2 | |
| Hydrochloric Acid SCHEMBL19747346 | 0.76 | CYP2D6 (0.31) | KCNH2 | |
| SCHEMBL23936940 | 0.73 | CARM1 (0.41) | BRD4MAPK14CARM1PRMT6MAPK1 | |
| SCHEMBL23936904 | 0.72 | TTK (0.38) | MAPK1 | |
| SCHEMBL21196782 | 0.63 | FPR2 (0.43) | MAPK1NPSR1KCNH2HRH3 | |
| SCHEMBL21196704 | 0.61 | CYBB (0.40) | MAPK1NPSR1KCNH2HRH3 | |
| SCHEMBL23922733 | 0.60 | P2RY14 (0.35) | MAPK1NPSR1CXCR3KCNH2 | |
| SCHEMBL21196720 | 0.60 | FPR2 (0.38) | MAPK1NPSR1KCNH2HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3475277-B1 | ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF | BIOIMICS AB (SE) | 2021-10-20 | — | — | EP | disclosed |